JP2017521090A5 - - Google Patents

Download PDF

Info

Publication number
JP2017521090A5
JP2017521090A5 JP2017512466A JP2017512466A JP2017521090A5 JP 2017521090 A5 JP2017521090 A5 JP 2017521090A5 JP 2017512466 A JP2017512466 A JP 2017512466A JP 2017512466 A JP2017512466 A JP 2017512466A JP 2017521090 A5 JP2017521090 A5 JP 2017521090A5
Authority
JP
Japan
Prior art keywords
polyplex
cancer
cooh
target moiety
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017512466A
Other languages
English (en)
Japanese (ja)
Other versions
JP6753843B2 (ja
JP2017521090A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/050514 external-priority patent/WO2015173824A1/en
Publication of JP2017521090A publication Critical patent/JP2017521090A/ja
Publication of JP2017521090A5 publication Critical patent/JP2017521090A5/ja
Priority to JP2020139643A priority Critical patent/JP7406475B2/ja
Application granted granted Critical
Publication of JP6753843B2 publication Critical patent/JP6753843B2/ja
Priority to JP2023211790A priority patent/JP2024028995A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017512466A 2014-05-14 2015-05-14 改善されたポリエチレンイミンポリエチレングリコールベクター Active JP6753843B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2020139643A JP7406475B2 (ja) 2014-05-14 2020-08-20 改善されたポリエチレンイミンポリエチレングリコールベクター
JP2023211790A JP2024028995A (ja) 2014-05-14 2023-12-15 改善されたポリエチレンイミンポリエチレングリコールベクター

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461993110P 2014-05-14 2014-05-14
US61/993,110 2014-05-14
PCT/IL2015/050514 WO2015173824A1 (en) 2014-05-14 2015-05-14 Improved polyethyleneimine polyethyleneglycol vectors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020139643A Division JP7406475B2 (ja) 2014-05-14 2020-08-20 改善されたポリエチレンイミンポリエチレングリコールベクター

Publications (3)

Publication Number Publication Date
JP2017521090A JP2017521090A (ja) 2017-08-03
JP2017521090A5 true JP2017521090A5 (https=) 2018-06-21
JP6753843B2 JP6753843B2 (ja) 2020-09-16

Family

ID=54479412

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017512466A Active JP6753843B2 (ja) 2014-05-14 2015-05-14 改善されたポリエチレンイミンポリエチレングリコールベクター
JP2020139643A Active JP7406475B2 (ja) 2014-05-14 2020-08-20 改善されたポリエチレンイミンポリエチレングリコールベクター
JP2023211790A Pending JP2024028995A (ja) 2014-05-14 2023-12-15 改善されたポリエチレンイミンポリエチレングリコールベクター

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020139643A Active JP7406475B2 (ja) 2014-05-14 2020-08-20 改善されたポリエチレンイミンポリエチレングリコールベクター
JP2023211790A Pending JP2024028995A (ja) 2014-05-14 2023-12-15 改善されたポリエチレンイミンポリエチレングリコールベクター

Country Status (16)

Country Link
US (4) US10278991B2 (https=)
EP (1) EP3142673A4 (https=)
JP (3) JP6753843B2 (https=)
KR (2) KR102589295B1 (https=)
CN (3) CN116966311A (https=)
AU (2) AU2015260725B2 (https=)
CA (1) CA2949017A1 (https=)
IL (2) IL287206B2 (https=)
MA (1) MA39970A (https=)
MX (2) MX377654B (https=)
NZ (1) NZ727092A (https=)
PH (1) PH12016502258B1 (https=)
RU (1) RU2771104C2 (https=)
SG (2) SG11201609442YA (https=)
WO (1) WO2015173824A1 (https=)
ZA (1) ZA201608042B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102589295B1 (ko) 2014-05-14 2023-10-13 타르그이뮨 테라퓨틱스 아게 개선된 폴리에틸렌이민 폴리에틸렌글리콜 벡터
HUE047172T2 (hu) 2015-11-17 2020-04-28 Bioncotech Therapeutics S L Újfajta gyógyszerészeti készítmény, mely egy kétszálú poli-ribonukleotid és egy polialkilén-imin egy komplexét tartalmazó részecskéket tartalmaz
JP6937773B2 (ja) * 2016-03-07 2021-09-22 ハンミ ファーマシューティカル カンパニー リミテッド ポリエチレングリコール誘導体及びその用途
BR112019004017A2 (pt) 2016-09-04 2019-06-25 Targimmune Therapeutics Ag proteínas quiméricas para direcionar dsrna
ES2924138T3 (es) 2017-05-17 2022-10-04 Highlight Therapeutics S L Nueva composición farmacéutica que comprende partículas que comprenden un complejo de un polirribonucleótido de doble cadena y una polialquilenimina
JP2020535171A (ja) * 2017-09-27 2020-12-03 ターグイミューン セラピューティクス アーゲー 去勢抵抗性前立腺癌
EP3762417A1 (en) * 2018-03-08 2021-01-13 TargImmune Therapeutics AG A recombinant protein comprising a double stranded rna binding domain
CN109893657B (zh) * 2019-02-28 2022-04-29 中国人民解放军军事科学院军事医学研究院 基因递送载体、药物复合物、抗肺纤维化药物及应用
CA3131535A1 (en) 2019-04-03 2020-10-08 Targimmune Therapeutics Ag Immunotherapy for the treatment of cancer
WO2020263782A1 (en) * 2019-06-24 2020-12-30 North Carolina State University Methods and compositions for modifying nucleic acids and for killing cells
WO2021001023A1 (en) * 2019-07-02 2021-01-07 Biontech Rna Pharmaceuticals Gmbh Rna formulations suitable for therapy
JP2023544201A (ja) * 2020-10-08 2023-10-20 ターグイミューン セラピューティクス アクチエンゲゼルシャフト がんを処置するための免疫療法
CA3237153A1 (en) 2021-11-05 2023-05-11 Targimmune Therapeutics Ag Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
US20240091348A1 (en) * 2022-09-20 2024-03-21 Highlight Therapeutics, S.L. Novel compositions based on polyinosinic-polycytidylic acid
KR20250105420A (ko) 2022-11-07 2025-07-08 타르그이뮨 테라퓨틱스 아게 핵산 및 폴리에틸렌이민 및 폴리에틸렌 글리콜을 포함하는 표적화된 컨쥬게이트의 다중복합체
EP4615511A1 (en) * 2022-11-07 2025-09-17 TargImmune Therapeutics AG Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
KR20250106292A (ko) 2022-11-07 2025-07-09 타르그이뮨 테라퓨틱스 아게 폴리에틸렌이민 및 폴리에틸렌 글리콜을 포함하는 psma 표적화 선형 컨쥬게이트 및 이들을 포함하는 다중복합체
WO2025238236A1 (en) 2024-05-16 2025-11-20 Targimmune Therapeutics Ag Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59106279D1 (de) 1990-05-18 1995-09-21 Genentech Inc Neue protein-polykation-konjugate.
DE4104186A1 (de) 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
IL103059A0 (en) 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
NZ244306A (en) 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
DE19726186A1 (de) 1997-06-20 1998-12-24 Boehringer Ingelheim Int Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
WO1999061032A1 (en) 1998-05-25 1999-12-02 Nippon Shinyaku Co., Ltd. Process for producing composite preparation containing nucleic acid
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
US20040043030A1 (en) 2001-07-31 2004-03-04 Immunomedics, Inc. Polymeric delivery systems
GB0119346D0 (en) 2001-08-08 2001-10-03 Bioclones Proprietary Ltd Process for the maturation of dendritic cells
US7060498B1 (en) 2001-11-28 2006-06-13 Genta Salus Llc Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
KR20030043780A (ko) 2001-11-28 2003-06-02 주식회사 바이오폴리메드 생체적합성 비항원성 공중합체와 그 결합체 및 이들의제조방법
WO2003072636A1 (en) 2002-02-28 2003-09-04 Jong Sang Park Cationic highly branched polyaminoester
CN1720257A (zh) 2002-08-06 2006-01-11 因特拉迪格姆公司 通过导入干扰rna在体内下调靶基因表达的方法
US7927792B2 (en) * 2002-11-18 2011-04-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Targeted double stranded RNA mediated cell killing
US8969543B2 (en) 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
US8324365B2 (en) 2003-04-03 2012-12-04 Korea Advanced Institute Of Science And Technology Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof
US7727969B2 (en) 2003-06-06 2010-06-01 Massachusetts Institute Of Technology Controlled release nanoparticle having bound oligonucleotide for targeted delivery
US20050118718A1 (en) 2003-09-22 2005-06-02 University Of Utah Research Foundation Stabilization and controlled delivery of ionic biopharmaceuticals
US20050277575A1 (en) 2004-03-24 2005-12-15 Alexandre Semov Therapeutic compositions and methods for treating diseases that involve angiogenesis
CA2587676A1 (en) 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
US7893244B2 (en) 2005-04-12 2011-02-22 Intradigm Corporation Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
CN101287500A (zh) * 2005-08-19 2008-10-15 恩多塞特公司 多药物配体缀合物
US20090011004A1 (en) 2005-12-30 2009-01-08 Philadelphia Health & Education Corp., D/B/A/ Drexel University Of College Of Medicine Improved carriers for delivery of nucleic acid agents to cells and tissues
US20070231392A1 (en) 2006-01-23 2007-10-04 Ernst Wagner CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
US20070225213A1 (en) 2006-03-23 2007-09-27 Kosak Matthew K Nucleic acid carriers for delivery of therapeutic agents
ES2776100T3 (es) 2006-03-31 2020-07-29 Massachusetts Inst Technology Sistema para el suministro dirigido de agentes terapéuticos
EP2136788B1 (en) 2007-03-30 2011-10-26 Bind Biosciences, Inc. Cancer cell targeting using nanoparticles
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
EP4464384A3 (en) 2007-08-17 2025-01-08 Purdue Research Foundation Psma binding ligand-linker conjugates and methods for using
WO2009030254A1 (en) * 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
EP2630966B1 (en) 2007-10-12 2017-04-19 Massachusetts Institute of Technology Vaccine nanotechnology
US20110027172A1 (en) 2007-12-10 2011-02-03 Zhuang Wang Drug delivery system for pharmaceuticals and radiation
US20110038888A1 (en) 2008-01-10 2011-02-17 Peter Emtage Adjuvant compositions comprising poly-ic and a cationic polymer
WO2009131435A1 (en) 2008-04-23 2009-10-29 Erasmus University Medical Center Rotterdam Linker containing bungarotoxin and a binding peptide
EP2113257A1 (en) 2008-04-30 2009-11-04 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
EP2123304A1 (en) 2008-05-23 2009-11-25 Freie Universität Berlin Compounds suited as nanocarriers for active agents and their use
WO2009151539A1 (en) 2008-05-24 2009-12-17 Sirnaomics, Inc. COMPOSITIONS AND METHODS USING siRNA MOLECULES FOR TREATMENT OF GLIOMAS
WO2010005740A2 (en) 2008-06-16 2010-01-14 Bind Biosciences, Inc. Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
WO2010073247A2 (en) * 2008-12-22 2010-07-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Egfr-homing double-stranded rna vector for systemic cancer treatment
WO2010088927A1 (en) 2009-02-09 2010-08-12 Curevac Gmbh Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
US20100266642A1 (en) 2009-02-20 2010-10-21 Bind Biosciences, Inc. Modified cells for targeted cell trafficking and uses thereof
ES2588183T3 (es) 2009-03-31 2016-10-31 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal
WO2010127159A2 (en) 2009-04-30 2010-11-04 Intezyne Technologies, Incorporated Polymeric micelles for polynucleotide encapsulation
ES2368963B1 (es) 2009-07-04 2012-10-10 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Procedimiento de identificación de agentes terapéuticos contra el melanoma y uso de agente identificado.
CN101638484A (zh) * 2009-08-24 2010-02-03 中国科学院长春应用化学研究所 聚乙二醇单甲醚-聚2-甲基-2-羧基碳酸丙烯酯接枝聚乙烯亚胺共聚物与制法及应用
CA2781717C (en) 2009-12-09 2017-09-12 Ibc Pharmaceuticals, Inc. Dock-and-lock (dnl) complexes for delivery of interference rna
JP6175237B2 (ja) 2009-12-15 2017-08-02 ファイザー・インク コルチコステロイドを含む治療用ポリマーナノ粒およびそれを製造かつ使用する方法
ES2780156T3 (es) 2009-12-15 2020-08-24 Pfizer Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
JP5898627B2 (ja) 2009-12-15 2016-04-06 バインド セラピューティックス インコーポレイテッド エポチロンを含む治療用ポリマーナノ粒子ならびにそれを製造および使用する方法
DK2539451T3 (da) 2010-02-24 2016-04-04 Arrowhead Res Corp Sammensætninger til målrettet tilførsel af siRNA
ES2631458T3 (es) 2010-03-04 2017-08-31 Interna Technologies B.V. Molécula de ARNmi definida por su fuente y sus usos terapéuticos en el cáncer asociado a la EMT
US20110256227A1 (en) 2010-04-14 2011-10-20 Intezyne Technologies, Inc. Controlled polyplex assembly
WO2011154331A1 (en) 2010-06-10 2011-12-15 F. Hoffmann-La Roche Ag Polymers for delivery of nucleic acids
EP2395041A1 (en) 2010-06-10 2011-12-14 F. Hoffmann-La Roche AG Polymers for delivery of nucleic acids
NZ704322A (en) 2010-07-06 2016-07-29 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
US20120207795A1 (en) 2010-07-13 2012-08-16 The Regents Of The University Of California Cationic polymer coated mesoporous silica nanoparticles and uses thereof
WO2012016188A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
FR2963350B1 (fr) 2010-07-30 2013-11-01 Univ D Evry Val D Essonne Nouveaux copolymeres a bloc et leurs utilisations pour delivrer une substance active dans une cellule.
US8461224B2 (en) 2011-03-04 2013-06-11 National Health Research Institutes Single monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery
US10029023B2 (en) 2011-03-31 2018-07-24 The Johns Hopkins University Theranostic imaging agents and methods of use
WO2012166923A2 (en) 2011-05-31 2012-12-06 Bind Biosciences Drug loaded polymeric nanoparticles and methods of making and using same
EP3272868A1 (en) 2012-05-02 2018-01-24 Arrowhead Pharmaceuticals, Inc. Organic compositions to treat kras-related diseases
EP2852668B1 (en) 2012-07-12 2016-04-27 ProQR Therapeutics II B.V. Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell
CA2912975A1 (en) 2012-10-16 2014-04-24 William Marsh Rice University An improved nanovector based drug delivery system for overcoming drug resistance
US10201556B2 (en) 2012-11-06 2019-02-12 Interna Technologies B.V. Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
BR112015011118B1 (pt) 2012-11-15 2022-12-13 Endocyte, Inc Conjugado; composição farmacêutica; e uso de um conjugado
EP2930180B1 (en) 2012-12-06 2021-11-10 Kyowa Hakko Bio Co., Ltd. Double-stranded ribonucleic acid for adjuvants
EP3013964B1 (en) 2013-06-28 2020-05-06 ethris GmbH Compositions for introducing rna into cells
CN104341488A (zh) 2013-08-02 2015-02-11 复旦大学 c(LyP-1)多肽及其构建的纳米递药系统和应用
WO2015065773A1 (en) 2013-11-04 2015-05-07 Northeastern University System for co-delivery of polynucleotides and drugs into protease-expressing cells
JP2017505104A (ja) 2013-11-08 2017-02-16 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド インビボにおける薬剤送達のための核酸ナノ構造体
MA39734B1 (fr) 2014-03-14 2019-07-31 Pfizer Nanoparticules thérapeutiques comportant un agent thérapeutique, et leurs procédés de fabrication et d'utilisation
EP3126501A1 (en) 2014-03-24 2017-02-08 RiboxX GmbH Double-stranded rna conjugates and their use
JP7348708B2 (ja) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 組み合わせワクチン装置および癌細胞を殺滅する方法
KR102589295B1 (ko) 2014-05-14 2023-10-13 타르그이뮨 테라퓨틱스 아게 개선된 폴리에틸렌이민 폴리에틸렌글리콜 벡터
US20180016352A1 (en) 2015-02-05 2018-01-18 The University Of Queensland Targeting constructs for delivery of payloads
US20160331845A1 (en) 2015-05-14 2016-11-17 The Johns Hopkins University Compositions of nucleic acid-containing nanoparticles for in vivo delivery
HUE047172T2 (hu) 2015-11-17 2020-04-28 Bioncotech Therapeutics S L Újfajta gyógyszerészeti készítmény, mely egy kétszálú poli-ribonukleotid és egy polialkilén-imin egy komplexét tartalmazó részecskéket tartalmaz

Similar Documents

Publication Publication Date Title
JP2017521090A5 (https=)
RU2016146389A (ru) Улучшенные полиэтилениминовые полиэтиленгликолевые векторы
ES2941768T3 (es) Compuestos de 2H-pirazolo[4,3-d]pirimidina como agonistas del receptor 7 tipo toll (TLR7) y métodos y usos para los mismos
US10696676B2 (en) Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor
ES2895369T3 (es) Agonistas del receptor tipo toll 7 (TLR7) que tienen un resto tricíclico, conjugados de estos y métodos y usos de estos
JP6328649B2 (ja) 薬物−タンパク質コンジュゲート
AU2018317857A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as toll-like receptor 7 (TLR7) agonists as immunostimulants
CA3072754A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as immunostimulant toll-like receptor 7 (tlr7) agonists
JPWO2020027100A5 (https=)
KR20200041910A (ko) 면역자극제 톨-유사 수용체 7 (tlr7) 효능제로서의 6-아미노-7,9-디히드로-8h-퓨린-8-온 유도체
JP2014088414A5 (https=)
US20250115679A1 (en) Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereof
CN114939174A (zh) 抗体-药物偶联物的共价连接子及其制备方法与应用
TW202537975A (zh) 抗體-藥物結合物之製造方法
JPWO2020059772A5 (https=)
JPWO2019230645A5 (https=)
JPWO2022102634A5 (https=)
IL302812A (en) Antibody-drug conjugate combinations with anti-SIRP alpha antibody
US20250205349A1 (en) Anti-human trop2 antibody-camptothecin drug conjugate and medical use thereof
CN120957755A (zh) 多环类药物偶联物及其制备方法和用途
JP2020099326A5 (https=)
NZ773646B2 (en) Amatoxin-antibody conjugates